Wearable Injectors Market – By Global Industry Analysis, Size, Share, Trends, Forecast 2016 – 2024

Wearable Injectors Market SizeThe global wearable injectors market is likely to grow from $2,162.1 million in 2015 to $13.0 billion by 2024. With the explosive growth of bolus injectors and increasing interest of pharmaceutical companies in collaborating with device manufacturers for drug device combination, the market for wearable injectors is expected to show dramatic rise. The launch of bolus injector expands the usage of wearable injectors from diabetes to other disease segments, as the wearable injectors currently available in market are majorly insulin pumps. The growing need for continuous and subcutaneous drug delivery has developed the demand for wearable injectors among the patients.

Explore Report Sample at: http://bit.ly/2fdS4t1

As per the findings of the research, cancer is expected to be the largest application area of wearable injectors. According to the analyst, cancer and autoimmune disease are expected to be the major application areas for wearable injectors in the near future. The other key applications of wearable injectors include infectious disease, cardiovascular disease and blood disorders. Also, homecare is expected to be the largest end user of wearable injectors.

Growing need for advanced drug delivery is one of the major factors driving the growth of the global wearable injectors market. Increasing demand for homecare and advanced drug delivery requiring minimal expertise and lesser hospitalization of patients is expected to drive the demand for wearable injectors, globally. Also, many biopharmaceutical companies have been looking for a better mode of drug delivery for their portfolio of biologic drugs, for which wearable injectors are an appropriate solution.

Access Report Overview: http://bit.ly/2yYp3sD

The research states that the global wearable injectors market had a consolidated structure in 2015, where the top three competitors accounted for the major share in the global wearable injectors market. Some of the key players operating in the global market are Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, CeQur SA, Enable Injections, ScPharmaceuticals, Inc., SteadyMed Ltd., Ypsomed Group, West Pharmaceutical Services, Inc. and Canè S.p.A.


Medical Supplies Market – Global Market Insights, Size and Growth, 2023

Medical Supplies Market

Medical supplies are the medical instrument and device supplies, that are used in various medical centers, medical institutions and hospitals. Various medical instruments and devices include thermometers, glucose meters, blood processing devices, wound care instruments and accessories, and monitoring systems. The demand for the medical supplies is experiencing an increasing trend since the market players are introducing technically advanced medical supplies that can aid medical professionals to handle their patients in a better way. The outpatient facilities and hospitals are adopting strict policies towards infection- prevention for better care of the patient, which is driving the growth of the market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/medical-supplies-market

Based on application, the global medical supplies market is segmented into urology, ophthalmology, radiology, anesthesia, sterilization, cardiology, wound care and others. Anesthesia was the largest application in 2016 due to increase in the number of surgical procedures performed and rise in respiratory diseases.

Based on type, the global medical supplies market is categorized into sterilization consumables, personal protective equipments (PPE), infusion products, radiology consumables, wound care consumables, diagnostic supplies, inhalation products, dialysis consumables, infection control supplies, intubation and ventilation supplies, hypodermic products, and other supplies. Among different types of medical supplies, dialysis consumable segment is expected to witness the fastest growth during the forecast period (2017-2023) due to increase in renal disease cases, rise in diabetic patients and aging population.

Global medical supplies market is expected to grow during the forecast period due to the growing population, increase in number of hospitals, rise in the frequency of communicable diseases, and aging population. Also, increase in medical conditions such as diabetes and renal disease, rise in surgeries, rise in hospital acquired infections and increase in awareness are driving the growth of the global medical supplies market. The increase in number of hospital acquired infection cases have significant positive impact on the growth of the global medical supplies market. According to the World Health Organization (WHO), every 10 people in developing countries and 7 in developed countries acquire at least one infection from hospital, of every 100-hospitalized patient, at any given point of time.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/medical-supplies-market/report-sample

Global medical supplies market is highly competitive and major players are acquiring smaller players to increase their market share. The key players in the global market are Boston Scientific, Medtronic plc, Baxter International Inc., Johnson & Johnson. Other players in this market are Cardinal Health Inc., Halyard Health Inc., Thermo Fisher Scientific, B. Braun, Becton, Dickinson and Company, and 3M Company.

Image Guided Surgery Devices Industry Outlook, Growth Prospects and Key Opportunities

Image Guided Surgery Devices Market AnalysisThe global image guided surgery devices market is likely to grow significantly during the forecast period, due to increasing prevalence of chronic diseases, and cancer, rising geriatric population and increasing cases of neurological disorders. In addition to these factors, rising healthcare expenditure and technological advancements in medical imaging also contributes to the growth of the overall market. High cost of imaging techniques and stringent regulatory requirements are some of the key factors restraining the global market growth.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/image-guided-surgery-devices-market/report-sample

As per the findings of the research, the CT is the largest segment, based on device type, in the global image guided surgery devices market. CT is a non-invasive, accurate and fast diagnostic imaging test. It uses x-ray equipment to produce 3D images by taking series of images from different angles. Each image created during the CT procedure shows the bones, tissues and organs in a thin “slice” of the body.

It provides cross-sectional images generated during the CT scan and can be reformatted in multiple planes. It is used for diagnosing skeletal abnormalities, blood clots, blood vessel aneurysm and cancer. Neurology has been the largest application area for image guided surgery devices, followed by orthopedic surgery, ENT surgery, oncology surgery and others.

Browse Report Description at: https://www.psmarketresearch.com/market-analysis/image-guided-surgery-devices-market

Some of the key players in the global image guided surgery devices market include Siemens AG, GE Healthcare, Koninklijke Philips N.V., Canon Inc., Hitachi, Ltd., KARL STORZ GmbH & Co. KG., Medtronic, Inc., St. Jude Medical, Inc., Varian Medical Systems, Inc., Smith & Nephew plc, Integra LifeSciences Corporation and Zimmer Holdings, Inc.


Smart Pulse Oximeters Market – Global Industry Size, Share and Growth, 2023

Smart Pulse Oximeters MarketSmart pulse oximeters are non-invasive medical devices that are used to measure various health parameters such as pulse rate, heart rate and oxygen saturation level. These devices help in the early detection of various diseases such as sleep problems, respiratory diseases, and cardiac diseases. However, smart pulse oximeters readings may get affected by low blood pressure, cold fingers, nail polish, and artificial nails. The smart pulse oximeters market is expected to have a considerable growth during the forecast period. According to the World Health Organization (WHO), around 3 million people died of chronic obstructive pulmonary disease (COPD), in 2015. It further reported that COPD is likely to increase in coming years due to higher smoking prevalence and aging populations in many countries. Therefore, the increasing prevalence of the respiratory diseases is expected to drive the growth of the global smart pulse oximeters market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/smart-pulse-oximeters-market

Based on product type, the smart pulse oximeter market is segmented into fingertip pulse oximeters, hand-held pulse oximeters, wrist-worn pulse oximeters, and pediatric pulse oximeters. Fingertip pulse oximeters held the largest share of the smart pulse oximeters market, in 2016, and is expected to maintain its position during the forecast period, mainly due to its light weight, ease of use, and rising prevalence of respiratory diseases. Moreover, WHO safety pulse oximetry project for the improvement in the health of the people in middle-income countries is also expected to further boost the growth of the smart pulse oximeters market.

Smart pulse oximeters market is expected to grow significantly during the forecast period. Some of the major factors driving growth of the global market are growing geriatric population, technological advancements, rise in prevalence of respiratory diseases, and growing demand for portable monitoring devices.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/smart-pulse-oximeters-market/report-sample

According to the United Nations Department of Economic and Social Affairs (UNDESA) report the number of people aged 60 years or over is projected to grow by 56%, globally, i.e. from 901 million in 2015 to 1.4 billion by 2030. Also, the global aging population is projected to reach nearly 2.1 billion, by 2050. Thus, with the rise in aging population, the use of smart pulse oximeters has been increasing for early detection of diseases.

Some of the key players in the global Smart pulse oximeters market are Contec Medical Systems Co., Ltd., General Electric Company, Halma PLC, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical, Inc., Omron Corporation, Smiths Group PLC, and Technocare Medisystems.

Surgical Simulation Market – Global Industry Analysis, Size, Growth, 2023

Surgical Simulation MarketSurgical simulation is a technology that is developed in order to stimulate surgical procedures for the purpose of training healthcare professionals, without using any subject such as a human body or animal. The key concept of surgical simulator is based on the video games that were developed in 1980’s, and now it offers advancements such as three-dimensional graphics, motion sensors for realistic movements in order to simulate the real situation. The trainings conducted to teach how to perform surgeries, using these simulators is known as surgical simulation. The global surgical simulation market is growing due an increase in the number of diseases, which has further led to a rise in the requirement of doctors. Doctors need to be trained about surgeries without actually involving a subject. The most common type of surgery that is being explained through this method is laparoscopic surgery, although it has also been used to do a trial run before other kinds of procedures. With public pressure for increased oversight of surgeons in training, prevention of medical errors, reduction in healthcare costs and decreased working hours, current doctors have a very different training experience these days, as compared to the past. Limited working hours have led to a reduced exposure of surgical trainees towards operative procedures and the ability to practice those associated technical skills. Bridging this educational gap has become important, since proficiency based evaluation overtakes the traditional time-based model.  Many now look to simulation as the possible solution for deficits emerging in current surgical training and as a way to improve patient safety and possibly overall costs. Surgical simulation is best suited for two types of skills, namely eye-hand coordination and the ability to perform three dimensional actions.

Explore Report at: http://bit.ly/2hX6E9D

The surgical simulation market is divided on the basis of application and end user. On the basis of application, surgical simulation is applied to various surgeries such as laparoscopic, gynecological, cardiovascular, arthroscopic physiotherapy, occupational therapy and others. The cardiovascular surgery accounts for holds the largest share of the market.

Technological innovations in simulators, rising demand for minimally invasive treatments, increasing focus on the safety of patient and increasing healthcare spending are some of the drivers supporting the growth of global surgical simulation market.

Request for Report Sample at: http://bit.ly/2i1dlrq

According to the Centers for Disease Control and Prevention (CDC), total national health expenditure in the U.S. was $3.0 trillion in 2014, and per capita national health expenditure was $9,523. According to the U.K. Office for National Statistics (ONS), the U.K.’s total healthcare expenditure was $297.8 billion in 2014.

Major key players in the global surgical simulation market include Laerdal Medical, 3D Systems Inc., Gaumard Scientific, Limbs & Things Ltd., Kyoto Kagaku Co. Ltd, Mentice AB, Simulab Corporation, Surgical Science Sweden AB, Simulaids Inc.

HIV Diagnosis Market Trends, Size, Growth and Future Scope

HIV Diagnosis Market

The global HIV diagnosis market is likely to grow significantly during the forecast period, due to rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits. In addition, rising healthcare expenditure on HIV and related activities further contributes to the growth of the overall market. High cost of automated HIV diagnosis procedures and lack of skilled professionals are some of the key factors restraining the growth of global HIV diagnosis market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market/report-sample

As per the findings of the research, based on products, consumables segment is the largest product category in the global HIV diagnosis market. Antibody test has been the largely performed test of the global HIV diagnosis market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.

The healthcare expenditure for the purpose of alleviating the potential epidemic situation of HIV, has increased over the past few years in many low and middle income as well as developing countries. According to the data published by UNAIDS, $19.0 billion was spent on the HIV and AIDS related activities in low- and middle-income countries in 2015, of which 57% came from domestic budgets of the governments of these countries. Considering the increasing incidence of HIV, the UNAIDS estimated that approximately $26.2 billion will be required to respond to the epidemic of HIV infection expected in 2020 and around $23.9 billion will be required for the same, in 2030. The variation in healthcare spending across regions is thought to be related to the relative burden of the disease in that region, which in case of Sub-Saharan Africa is significantly high. The overall healthcare spending on HIV and related activities has increased over the years, which in turn is expected to drive the growth of the global HIV diagnosis market.

Browse Report Description at: https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market

Some of the key players in the global HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.

New Growth Opportunities lie in the Asia-Pacific Active Implantable Medical Devices Market, 2023

Active-Implantable-Medical-Devices-MarketThe global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market/report-sample

As per the findings of research, implantable cardioverter defibrillators held the largest share in the global active implantable medical devices market in 2016, primarily due to the development of technologically advanced devices and increasing prevalence of cardiovascular diseases. The neurostimulators market is expected to witness the highest growth during the forecast period. This growth of neurostimulators is attributed to the increasing incidence of neurological disorders and increasing demand from emerging economies. Among different type of implantable cardioverter defibrillators, transevenous implantable cardioverter defibrillators held larger share in the global active implantable medical devices market in 2016, and it is also expected to witness higher growth during the forecast period. Increasing research and development activities and rising compliance for technological innovations and data driven customizations are driving the growth of the global transvenous implantable cardioverter market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market

Active Implantable Medical Devices Market

Key companies in the active implantable medical devices market are acquiring other companies to strengthen their position in the global market. In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., including its atrial fibrillation, structural heart and heart failure business as well as neuromodulation business. Similarly, in January 2015, Medtronic plc completed the acquisition of Covidien plc. Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. The acquisition strengthened position of the company in the global market with a large number of product offerings.

Some of the other key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL.

Orthopedic Devices Market – Global Industry Analysis, Size and Demand, 2023

Orthopedic Devices Market

Orthopedics is a branch of medicine that is concerned with the prevention of disorders, deformities or injuries of the skeleton and associated structures such as tendons and ligaments. Orthopedic devices are used to implant and restore the skeletal structure and joint movement after the disorders such as fractures, abnormal growth of bones, soft tissue damage and other deformities. Orthopedic devices had been used effectively in reducing pain, restoring mobility and improving quality of life of the consumers across the globe. Before implanting an orthopedic device into patient’s body, doctors check x-ray and scan report of patient to diagnose the disorders. Doctors implant orthopedic devices that are well suited for the patient’s body, as most of the devices have to remain in the body for the remaining life of patient.

For more information visit: https://www.psmarketresearch.com/market-analysis/orthopedic-devices-market

In orthopedic devices, generally metal alloys are used due to their properties such as rigidity, fracture toughness, corrosion resistance, long fatigue life, stiffness, and biocompatibility. Whereas, polymers are used as articulating surfaces of joint replacements and as a cementing material between implant surfaces and bone. Polyether ether ketone (PEEK) implants are generally used for spinal implants as it has advantages such as high mechanical strength.

The various devise types available in the global orthopedic devices market are joint reconstruction, orthobiologics, trauma fixation devices, spinal devices, orthopedic accessories, orthopedic braces, and arthroscopic devices.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/orthopedic-devices-market/report-sample

North America dominates the global orthopedic devices market, attributed to high per capita expenditure on the healthcare services in the region. Asia-Pacific is the fastest growing market for orthopedic devices owing to the large population, increasing incidence of lifestyle diseases and development of modern healthcare service industry in the region.

Some of the major companies operating in the orthopedic devices market are Zimmer Holdings Inc., Medtronic Inc., Wright Medical Technology Inc., Orthofix Holdings Inc., NuVasive Inc., TriMed Inc., Stryker Corporation, Smith & Nephew PLC, Small Bone Innovations Inc., Solana Surgical LLC, DePuy Synthes Inc. Integra LifeSciences, Aesculap, Inc., and ArthroCare Corporation.

Pre-Clinical Imaging (In-vivo) Market – Global Industry Analysis, Size and Future Scope

Pre-Clinical Imaging MarketThe global pre-clinical imaging (in-vivo) market is growing significantly due to development of high resolution and sensitive imaging devices with various applications in the industry. Massive unexplored market in pre-clinical imaging (in-vivo) industry of developing economies are creating ample opportunities for the pre clinical imaging market to grow at a considerable rate in the coming years. Further, technological advancement in pre-clinical imaging will support the growth of the global pre-clinical imaging (in-vivo) market in the coming years.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/pre-clinical-imaging-market/report-sample

Pre-clinical (in-vivo) imaging is bridging a gap between the vivo clinical research and vitro exploratory. It is increasingly being deployed across the drug development process, specifically in oncology therapeutic area. The advanced research and development facilities and new product developments of the companies are supporting the growth of pre-clinical imaging (in-vivo) industry. Moreover, integration of pre-clinical MRI systems with other imaging modalities is also expected to propel the growth of the global pre-clinical imaging market in coming years.

On the basis of type of modalities of pre-clinical imaging (in-vivo), the market can be categorized as optical imaging systems, pre-clinical nuclear imaging systems, micro-magnetic resonance imaging (MRI), micro-ultrasound, micro-CT, pre-clinical photoacoustic imaging system, pre-clinical magnetic particle imaging system and others. The optical imaging system lead the pre-clinical imaging (in-vivo) market, by type of modalities category; whereas, the pre-clinical nuclear imaging system segment is expected to grow with the fastest rate in the coming years due to rising adoption of pre-clinical imaging and development of technologically hybrid nuclear imaging systems.

Explore Report at: https://www.psmarketresearch.com/market-analysis/pre-clinical-imaging-market

Some of the companies operating in the pre-clinical imaging (in-vivo) market are Perkinelmer Inc., Mr Solutions Ltd., Mediso Ltd., Bruker Corporation, Trifoil Imaging, Fujifilm Visualsonics Inc., Biospace Lab S.A., Milabs B.V., Li-Cor Biosciences, Thermo Fisher Scientific, Agilent Technologies and Aspect Imaging.


Ophthalmology Devices Market Analysis, Drivers, Trends, Challenges and Demand, 2023

Ophthalmology Devices Market

The global ophthalmology devices market is growing significantly due to increasing prevalence of eye diseases, and technological advancements in ophthalmic devices. Shortages of ophthalmology devices providers in emerging economies and increasing age-related eye diseases are creating ample opportunities for the ophthalmology devices market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective ophthalmic devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/ophthalmology-devices-market

The ophthalmology devices market is segmented on the basis of therapeutic applications, end-users, and products type. Based on therapeutic applications, the ophthalmology devices market can be categorized as diabetes retinopathy, cataract, macular degeneration, glaucoma, and others. Cataract leads the ophthalmology devices market due to high prevalence of cataract worldwide. Based on end-user, the ophthalmology devices market can be segmented as academic institutes and research laboratories, hospitals and others.

On the basis of products type, the ophthalmology devices market can be categorized as vision care devices, diagnostic devices, and surgical devices. The diagnostic devices segment includes optical coherence tomography (OCT) scanners, ophthalmic ultrasound imaging systems, fundus camera, retinoscopes and ophthalmoscopes, corneal topographers, visual field analyzers, tonometers, slit lamps, specular microscope, wavefront aberrometers, autorefractors, biometer, optotype projectors, and others. The surgical devices segment includes vitreoretinal surgery devices, cataract surgery devices, glaucoma surgery devices, and refractive surgery devices. Whereas, vision care devices segment includes spectacle lenses and contact lenses. Vision care devices segment is expected to grow with the fastest rate in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/ophthalmology-devices-market/report-sample

Some of the major players operating in the global ophthalmology devices market are Alcon Inc., Bausch & Lomb Inc., Abbott Medical Optics, Topcon Corporation, Carl Zeiss Meditec AG, Haag Streit, Johnson & Johnson, Nidek Co. Ltd., STAAR Surgicals, Hoya Corporation, Essilor International S.A., and Zeimer Ophthalmic Systems AG among others.